TrialFind
Saved trials
Back to results
Completed
Phase 1
A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects
NCT00625859
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
GSK Investigational Site
Buffalo, New York, United States
View on ClinicalTrials.gov
Official details
A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects — TrialFind